Assessing and Implementing Non-Prescription Treatments for Major Depressive Disorder

Abstract

Major Depressive Disorder is a mental health disorder that is classified as a prolonged depressed mood and loss of interest or pleasure in activities that were once enjoyed. Treatments vary per case and typically consist of a prescription drug to combat the disorder. In the US, MDD currently affects females at 8.7% and males at 5.3% (Major Depression). There are alternative treatments that could potentially aid patients. The pricing of treatment plans may be a factor in the treatment accessibility and feasibility. There’s a possibility that an increase in cognitive-behavioral therapy accessibility will lead to higher rates of MDD recovery.